Covid-19 Press Releases

09.09.2020

Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19

09.09.2020

Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

08.20.2020

Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19

08.07.2020

Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19

07.31.2020

Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate

04.09.2020

Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development

04.09.2020

Pfizer Advances Battle Against COVID-19 on Multiple Fronts

04.01.2020

Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic

03.17.2020

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

03.17.2020

Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine

03.13.2020

Pfizer Outlines Five-Point Plan to Battle COVID-19